Moss. Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium. Am J Physiol Heart Circ Physiol 287: H1756 -H1761, 2004. First published May 27, 2004 10.1152/ajpheart.00172.2004.-Transgenic mice expressing an allele of cardiac troponin T (cTnT) with a COOH-terminal truncation (cTnTtrunc) exhibit severe diastolic and mild systolic dysfunction. We tested the hypothesis that contractile dysfunction in myocardium expressing low levels of cTnT trunc (i.e., Ͻ5%) is due to slowed cross-bridge kinetics and reduced thin filament activation as a consequence of reduced cross-bridge binding. We measured the Ca 2ϩ sensitivity of force development [pCa for halfmaximal tension generation (pCa50)] and the rate constant of force redevelopment (k tr) in cTnTtrunc and wild-type (WT) skinned myocardium both in the absence and in the presence of a strong-binding, non-force-generating derivative of myosin subfragment-1 (NEM-S1). Compared with WT mice, cTnTtrunc mice exhibited greater pCa50, reduced steepness of the force-pCa relationship [Hill coefficient (n H)], and faster k tr at submaximal Ca 2ϩ concentration ([Ca 2ϩ ]), i.e., reduced activation dependence of ktr. Treatment with NEM-S1 elicited similar increases in pCa 50 and similar reductions in nH in WT and cTnT trunc myocardium but elicited greater increases in ktr at submaximal activation in cTnTtrunc myocardium. Contrary to our initial hypothesis, cTnTtrunc appears to enhance thin filament activation in myocardium, which is manifested as significant increases in Ca 2ϩ -activated force and the rate of cross-bridge attachment at submaximal [Ca 2ϩ ]. Although these mechanisms would not be expected to depress systolic function per se in cTnT trunc hearts, they would account for slowed rates of myocardial relaxation during early diastole. calcium ion sensitivity of force; kinetics of actin-myosin interaction; skinned myocardium IT SEEMS LIKELY that familial hypertrophic cardiomyopathy (FHC) mutations in the T 2 domain of cardiac troponin T (cTnT) would alter thin filament activation by perturbing its interactions with other thin filament proteins. This idea can be tested experimentally by assessing the effects on contraction due to incorporation of mutant cTnT into the thin filament. One FHC mutation, cTnT truncation (cTnT trunc ), involves a splicesite donor mutation in the cTnT gene, which results in a shift in the reading frame and premature termination (20). The resulting RNA transcript, lacking exons 15 and 16, encodes a truncated protein that is missing the COOH-terminal 28 amino acid residues. Deletion of the COOH-terminal residues of TnT has been shown to have important functional effects, presumably due to its interactions with the troponin
IT SEEMS LIKELY that familial hypertrophic cardiomyopathy (FHC) mutations in the T 2 domain of cardiac troponin T (cTnT) would alter thin filament activation by perturbing its interactions with other thin filament proteins. This idea can be tested experimentally by assessing the effects on contraction due to incorporation of mutant cTnT into the thin filament. One FHC mutation, cTnT truncation (cTnT trunc ), involves a splicesite donor mutation in the cTnT gene, which results in a shift in the reading frame and premature termination (20) . The resulting RNA transcript, lacking exons 15 and 16, encodes a truncated protein that is missing the COOH-terminal 28 amino acid residues. Deletion of the COOH-terminal residues of TnT has been shown to have important functional effects, presumably due to its interactions with the troponin I (TnI)-troponin C (TnC) complex (8) and with tropomyosin (Tm) (17) . Deletion of residues 216 -263 of the T 2 domain of TnT also results in reduced binding of TnI-TnC to the thin filament (8) . The severity of the cTnT trunc mutation is evident in studies in which even low levels (8 -10%) of expression in mice result in stillbirth or death within 24 h after birth (19) . The cTnT trunc mutation has been shown to have a range of effects on thin filament activation, including an increase in Ca 2ϩ sensitivity of force (10) , reduced cTnT-induced inhibition of actin-Tm-activated myosin ATPase activity, and an inability to inhibit Tm/actin thin filaments in the in vitro motility assay (14) . Other studies have shown that cTnT trunc destabilizes the binding of Tn to the thin filament, which affects the transitions between states that regulate myosin binding (3) . This mutation has also been shown to cause severe diastolic dysfunction and mild hypocontractile systolic dysfunction in whole heart preparations (19) . Such findings are consistent with the idea that cTnT influences the extent and possibly the kinetics of crossbridge binding and thereby contributes to the regulation of force development.
In the present study we examined the effects of the cTnT trunc mutation on the kinetics of cross-bridge binding to the thin filament and thin filament responsiveness to the activating effects of strong-binding cross bridges. We show that cTnT trunc directly affects thin filament activation by accelerating the rate of cross-bridge binding under basal conditions and enhances the sensitivity of the thin filament to the activating effects of Ca 2ϩ and strong-binding cross bridges.
MATERIALS AND METHODS
Transgenic mice expressing truncated cTnT. Transgenic mice expressing truncated cTnT (cTnT trunc) were generated as described previously (19) . Expression of the transgene was driven by the murine ␣-myosin heavy chain promoter, which restricts expression of cTnT trunc to cardiac muscle. Previous studies documented that transgenic mice expressing Ͼ10% of total cTnT as cTnTtrunc die within hours of birth (19) . To ensure survival for mechanical measurements, transgenic mice that expressed relatively low levels of cTnT trunc, i.e., Ͻ5% total TnT, were studied (19) . Analysis of global ventricular function has documented that mice expressing cTnT trunc at levels comparable to those in the current study exhibit significant diastolic dysfunction (19) . Compared with wild-type (WT) littermate controls, transgenic mice expressing low levels of cTnT trunc exhibited no gross phenotypic abnormalities, no change in mortality, and no apparent ventricular hypertrophy. Transgenic animal production and animal usage were conducted under strict guidelines established by animal use committees at the University of Colorado and the University of Wisconsin.
Skinned myocardial preparations. The methods used for preparing skinned myocardium for mechanical measurements under isometric conditions were described previously (13) . After intraperitoneal injection of 5,000 U heparin/kg body wt, WT and cTnT trunc mice (8 -12 mo old) were anesthetized with inhaled isoflurane. Their hearts were excised, and right and left ventricles were dissected in Ringer solution (in mM: 118 NaCl, 4.8 KCl, 2 NaH 2PO4, 1.2 MgCl2, 25 HEPES, 11 glucose, and 0.5 CaCl 2; pH 7.4, 22°C). Both ventricles were then rapidly frozen in liquid nitrogen, a step that was essential for obtaining high-quality preparations (13) . To prepare skinned myocardium, pieces of frozen ventricle were thawed and homogenized for ϳ4 s in ice-cold relaxing solution (in mM: 100 KCl, 20 imidazole, 7 MgCl 2, 2 EGTA, and 4 ATP; pH 7.0) with a Polytron homogenizer, which yielded multicellular preparations of 100 -250 m ϫ 600 -900 m. The homogenate was centrifuged at 120 g for 1 min, and the resulting pellet was washed with fresh relaxing solution and resuspended in relaxing solution containing 250 g/ml saponin and 1% Triton X-100. After 30 min, the skinned preparations were washed three times with fresh relaxing solution and were dispersed in ϳ50 ml of relaxing solution in a glass petri dish. The dish was kept on ice at all times except during the selection of individual preparations for mechanical experiments.
Experimental solutions, apparatus, and protocol. Solution compositions were calculated with the computer program of Fabiato (4) and stability constants (corrected to pH 7.0 and 15°C) listed by Godt and Lindley (7). All solutions contained (in mM) 100 N,N-bis (2- ]free) (i.e., pCa 6.5-5.5) were prepared by mixing appropriate volumes of solutions of pCa 9.0 and pCa 4.5.
Skinned preparations with well-defined edges and no free ends evident in the middle region were transferred from the petri dish to a stainless steel experimental chamber (11) containing relaxing solution. The ends of a preparations were attached to the arms of a motor (model 312B, Aurora Scientific) and a force transducer (model 403; Aurora Scientific) as described previously (11) . The chamber assembly was then placed on the stage of an inverted microscope (Olympus) fitted with a ϫ40 objective and a CCTV camera (model WV-BL600; Panasonic). Light from a halogen lamp was passed through a cut-off filter (transmission Ͼ620 nm) and was used to illuminate the skinned preparations. Bitmap images of the preparations were acquired with an AGP 4X/2X graphics card and associated software (ATI Technologies) and were used to assess mean sarcomere length (SL) during the course of each experiment. Changes in force and motor position were sampled (16-bit resolution, DAP5216a; Microstar Laboratories, Bellevue, WA) at 2.0 kHz with SLControl software developed in our laboratory (http://www.slcontrol.com) and saved to computer files for later analysis. Changes in force were also recorded on a chart recorder with a slow time base.
At the start of each experiment, the preparation was stretched to a mean SL of ϳ2.20 m for measurements of steady-state Ca 2ϩ -activated force and the rate constant of force redevelopment (ktr) after a release and restretch maneuver (2) . The force recorded in a solution of pCa 9.0 was taken as resting force and then subtracted from the total force in activating solutions to yield the Ca 2ϩ -activated force (P). The values of ktr reported here were determined as the rate constant of force redevelopment after the release and restretch of Ca 2ϩ -activated preparations (Fig. 1) . Mechanical measurements of steady-state Ca 2ϩ -activated force and the rate of force redevelopment were repeated after 15-min incubations of the preparations in pCa 9.0 solution containing either 3 M or 6 M non-force-generating derivative of myosin subfragment-1 (NEM-S1) (5) . At the end of each experiment, the preparation was cut free, placed in SDS sample buffer, and stored at Ϫ80°C until subsequent analysis of contractile protein content analysis by 12% SDS-PAGE (5). Gels were stained with silver and scanned with a densitometer (Molecular Analyst; Bio-Rad). Data analysis. Cross-sectional areas of skinned preparations were calculated by assuming that the preparations were cylindrical and by measuring width of the mounted preparation. Submaximal Ca 2ϩ -activated force (P) was expressed as a fraction of the maximum Ca 2ϩ -activated force (Po) generated at pCa 4.5, i.e., P/Po. Force-pCa data were fitted with the Hill equation:
, where nH is the slope (Hill coefficient) and k is the [Ca 2ϩ ] required for half-maximal activation. Rate constants of force redevelopment (ktr) were determined by linear transformation of the half-time of force recovery [k tr ϭ Ϫln 0.5 ϫ (t1/2) Ϫ1 ] (5, 13). All data are reported as means Ϯ SE. Comparisons between WT and cTnTtrunc data in the absence of NEM-S1 were made with an unpaired t-test and, when appropriate (nonparametric data), with the Wilcoxon Mann-Whitney test. To evaluate the effects of NEM-S1 on WT or cTnTtrunc myocardium, ANOVA with a Tukey post hoc test was used or, when appropriate, the Wilcoxon Mann-Whitney test. Significance level was set at P Ͻ 0.05. Fig. 1 . Experimental protocol for determination of Ca 2ϩ -activated force and rate constant of force redevelopment (ktr) in skinned myocardium. Bottom: changes in force recorded before, during, and after a step change in length (top) of the skinned myocardium. Once Ca 2ϩ -activated force reached steady state in a solution of pCa 4.5, muscle length was rapidly reduced by 20%. The amplitude of Ca 2ϩ -activated force was determined by subtracting the resting force measured at pCa 9.0 from the total force generated at pCa 4.5. After ϳ20 ms of unloaded shortening, the preparation was restretched to its original length. ktr was calculated as the apparent rate constant of force redevelopment after restretch of the muscle to its original length.
RESULTS

Mechanical properties of skinned WT and TnT trunc myocardium.
TnT trunc and WT myocardium generated comparable resting forces and maximum Ca 2ϩ -activated forces (Table 1) . In both cases, the force-pCa relationship was sigmoidal and was well fit with the Hill equation (Fig. 2) . In the absence of NEM-S1, mean pCa 50 was 5.81 Ϯ 0.01 in WT myocardium and 5.92 Ϯ 0.02 in TnT trunc myocardium, indicating that the Ca 2ϩ sensitivity of force was greater in TnT trunc myocardium (⌬pCa 50 ϭ 0.11 Ϯ 0.01; P Ͻ 0.01). Furthermore, the steepness of the force-pCa relationship was markedly reduced in TnT trunc compared with WT myocardium (n H was 3.6 Ϯ 0.1 in TnT trunc vs. 4.3 Ϯ 0.2 in WT; P Ͻ 0.001), indicating that low levels of TnT trunc expression reduce the apparent cooperativity of force development.
The k tr after rapid release and restretch of myocardium is frequently used to estimate the kinetics of cross-bridge cycling in contracting muscle. Representative traces showing the Ca 2ϩ dependence of the kinetics of force redevelopment in WT and TnT trunc myocardium are shown in Fig. 3 . At pCa 4.5, the mean values of maximal k tr recorded in WT myocardium did not differ from those recorded in TnT trunc myocardium (Table 1) . In both WT and TnT trunc myocardium, k tr varied with the level of Ca 2ϩ activation (Fig. 4A ), although expression of TnT trunc significantly reduced the Ca 2ϩ -dependent increase in k tr . The k tr increased more than fourfold in WT myocardium (from 4.10 Ϯ 0.16 s Ϫ1 at pCa 6.0 to 17.21 Ϯ 0.60 s Ϫ1 at pCa 4.5), which is consistent with the results of earlier studies (1, 6, 15, 25) , but only threefold in TnT trunc myocardium (from 5.29 Ϯ 0.22 s Ϫ1 at pCa 6.1 to 17.24 Ϯ 0.50 s Ϫ1 at pCa 4.5). The k tr was also plotted as a function of steady-state isometric force at each pCa to assess the variation in k tr with a variable that reflects the overall level of thin filament activation. In both WT and TnT trunc myocardium, k tr increased as a function of increasing isometric force, gradually at lower forces and more steeply at high forces (Fig. 4B) . However, at low forces expression of TnT trunc resulted in values of k tr that were greater than WT values. These data suggest that expression of TnT trunc enhances the cooperativity of thin filament activation.
Effects of NEM-S1 on mechanical properties of skinned WT and TnT trunc myocardium. The effects of 3 and 6 M NEM-S1 on resting force, maximum Ca 2ϩ -activated force, Ca 2ϩ sensitivity of force (pCa 50 ), and the steepness of the force-pCa relationship are summarized in Table 1 . In both WT and TnT trunc myocardium, NEM-S1 increased both resting force and submaximal Ca 2ϩ -activated forces in a concentrationdependent manner. Mean pCa 50 increased significantly in both WT and TnT trunc myocardium after treatment with 3 M NEM-S1, indicating an increase in the Ca 2ϩ sensitivity of force. Qualitatively similar increases in mean pCa 50 were observed after treatment with 6 M NEM-S1. In addition, treatment with 3 or 6 M NEM-S1 significantly reduced the steepness of the force-pCa relationships in both WT and TnT trunc myocardium, an observation consistent with results reported previously in skinned ventricular myocardium (6) .
Treatment with either 3 or 6 M NEM-S1 had no appreciable effect on the kinetics of force redevelopment in maximally activated preparations. However, at low levels of Ca 2ϩ activation, NEM-S1 had concentration-dependent effects on k tr . In both WT and TnT trunc myocardium, treatment with 3 or 6 M Data are presented from 10 wild-type and 10 transgenic mice. All values are expressed as means Ϯ SE, with the number of cardiac fiber preparations given in parentheses. NEM-S1, non-force-generating derivative of myosin subfragment-1; Po, maximum Ca 2ϩ -activated tension at pCa 4.5; Prest, Ca 2ϩ -independent tension at pCa 9.0; nH, Hill coefficient for total tension-pCa relationship; pCa50, pCa required for half-maximal tension generation; ktr, rate of force redevelopment at pCa 4.5. *Significantly different from control (P Ͻ 0.05); †significantly different from wild type (P Ͻ 0.05). NEM-S1 increased k tr at low levels of activation to values identical to k tr obtained in maximally activated preparations. At intermediate levels of activation, NEM-S1 increased k tr to greater than control values, but k tr was still less than maximal. Also, the k tr values obtained at intermediate levels of activation in the presence of NEM-S1 were significantly greater in TnT trunc myocardium than in WT myocardium.
DISCUSSION
Summary. Earlier functional studies on whole hearts isolated from cTnT trunc transgenic mice indicated that the mutation induced severe diastolic dysfunction and mild hypocontractile systolic dysfunction (19) , whereas studies in reduced systems found that the cTnT trunc mutation increased the Ca 2ϩ sensitivity of force (10) , reduced the inhibition of actin-activated myosin ATPase activity in regulated thin filaments, and reduced inhibition of sliding in an in vitro motility assay comprised of regulated thin filaments (14) . Although the mechanisms underlying this range of phenotypes are likely to be complex, an hypothesis that is consistent with these findings is that cTnT trunc directly affects cross-bridge transitional rate constants such that the rate of force development is slowed by reductions in the apparent rate constants of both attachment and detachment of cross bridges from actin. In fact, our results showed that the opposite was the case: at submaximal activations cTnT trunc myocardium exhibited faster rates of force development (Fig. 4A) , implying that the rates of cross-bridge attachment or detachment or both were accelerated compared with WT myocardium. Our results further show that at least some of these effects of the cTnT trunc mutation were a consequence of greater cross-bridge recruitment and increased thin filament responsiveness to the activating effects of Ca 2ϩ and strong-binding cross bridges.
Altered Ca 2ϩ sensitivity of force and apparent cooperativity in cTnT trunc myocardium. Previous studies reported that expression of cTnT trunc reduced maximal Ca 2ϩ -activated force compared with controls (12, 24) . Our results did not reproduce this effect, and because the maximal rates of force redevelopment (k tr ) did not differ between cTnT trunc and WT myocardium, a reduction in maximal Ca 2ϩ -activated force is not likely to contribute to the changes in cross-bridge kinetics observed in cTnT trunc myocardium at submaximal activations.
Our data also show that transgenic expression of small amounts (Ͻ5%) of cTnT trunc produced dramatic effects on Ca 2ϩ sensitivity of force and the apparent cooperativity of thin filament activation, as indicated by changes in n H . The pCa required at half-maximal activation (pCa 50 ) was shifted to lower [Ca 2ϩ ] by 0.11 units (Fig. 2) in transgenic myocardium compared with WT myocardium, indicating that less Ca 2ϩ is required to produce the same amount of force as controls. This finding agrees well with results of Montgomery et al. (10), who reported a 0.14-pCa unit shift in the tension-pCa relationship in the same cTnT trunc mice compared with WT myocardium.
Another notable finding is that n H , an index of apparent cooperativity in the activation of force, was reduced in cTnT trunc myocardium as evidenced by the shallower slope of the force-pCa relationship (Fig. 2) . This phenomenon was observed earlier by other investigators (3) and may manifest a diminished capacity of the Tm-Tn complex to inhibit crossbridge binding. Impaired suppression of myosin binding at low levels of Ca 2ϩ is consistent with slowed and incomplete diastolic relaxation and may indirectly give rise to diminished systolic function in cTnT trunc mice (19) . It has been suggested that the TnT truncation destabilizes the blocked conformation of the thin filament regulatory strand, which enhances the transition from the blocked to the active state. Thus, in cTnT trunc myocardium, there is greater likelihood that the thin filament will assume the "switched-on" state even at low [Ca 2ϩ ] and thereby reduce cooperativity in myosin binding to actin (3, 23) .
Accelerated cross-bridge kinetics in cTnT trunc myocardium. Although cTnT trunc had no effect on the maximal rate of force redevelopment compared with control, the mutation increased k tr at submaximal [Ca 2ϩ ] (Fig. 4) . Such increases could be due to a direct effect of the mutation on cross-bridge cycling kinetics or an indirect effect of increased cross-bridge binding to the thin filament. Both mechanisms appear to be operational in cTnT trunc myocardium, because some of the difference in rates between cTnT trunc and WT disappeared when results were plotted against relative force as a measure of Ca 2ϩ activation; however, at P/P o less than ϳ0.4, k tr was still faster in cTnT trunc myocardium. The reduction in difference between cTnT trunc and WT myocardium when k tr was plotted against force implies that some of the difference (Fig. 4A ) is due to acceleration of k tr in cTnT trunc myocardium secondary to the activating effects of greater numbers of cross bridges bound to the thin filament. The observation that some of the difference persists at low levels of activation suggests that cTnT trunc also has direct effects to accelerate cycling kinetics. In this regard, it is important to reiterate that the acceleration of k tr at low levels of Ca 2ϩ activation was observed despite low levels of cTnT trunc expression (19) . Incorporation of Ͻ5% cTnT trunc into the thin filament was sufficient to elicit a significant increase in the rate of force redevelopment in the absence of NEM-S1 (Fig. 4B) .
Earlier measurement of ATPase activity is consistent with these results. Montgomery et al. (10) reported that maximal ATPase cycling rates did not differ between WT and cTnT trunc ; however, the ATPase activity-pCa relationship was shifted to lower [Ca 2ϩ ] in cTnT trunc , indicating that cross-bridge cycling rates were increased at submaximal [Ca 2ϩ ]. Reports of increased sliding speed of actin filaments in in vitro motility assays (14, 22) , decreased inhibition of ATPase activity in the absence of Ca 2ϩ (18) , and the accelerated k tr at low Ca 2ϩ observed in the present study are consistent with the idea that cTnT trunc attenuates inhibition of thin filaments at low Ca 2ϩ . This phenomenon can also be interpreted in terms of a three-state model of thin filament activation (9) , which could result in incomplete relaxation. An increased number of strongly bound cross bridges at low levels of Ca 2ϩ activation would also be expected to accelerate the rate of force redevelopment because of the greater activating affects of cross bridges already bound to the thin filament. This model implies that incomplete inactivation of cTnT trunc thin filaments is most likely due to an incomplete return of Tm to the fully blocked position in the absence of Ca 2ϩ .
Effects of NEM-S1 on Ca
2ϩ sensitivity of force and cooperativity in activation of force. In this study, NEM-S1 was used to assess the effects of strong-binding cross bridges on thin filament activation in WT and cTnT trunc myocardium. As previously shown in rat myocardium (6), NEM-S1 slightly increases Ca 2ϩ independent tension at pCa 9.0, a phenomenon that was similar in WT and cTnT trunc myocardium. Furthermore, NEM-S1 markedly increased the Ca 2ϩ sensitivity of force in both WT and cTnT trunc myocardium, shifting the force-pCa relationships to lower [Ca 2ϩ ] by similar amounts and having similar effects on WT and transgenic myocardium. Thus, although the cTnT trunc mutation increased the Ca 2ϩ sensitivity of force, it had no obvious effects on the cooperative activation of steady-state isometric force by strong-binding cross bridges.
Effects of NEM-S1 on rate constant of force redevelopment. Earlier studies from this laboratory (6) showed that NEM-S1 accelerates the rate of force development in rat skinned myocardium, presumably due to increased activation of the thin filament as a consequence of greater numbers of cross bridges bound to actin. In the present work, NEM-S1 increased k tr in both cTnT trunc and WT myocardium but had greater effects in cTnT trunc myocardium. In both WT and transgenic myocardium, the NEM-S1-induced acceleration of force development at submaximal [Ca 2ϩ ] reduced the activation dependence of k tr . NEM-S1 had no effect on maximal k tr (measured at pCa 4.5) and increased k tr at very low [Ca 2ϩ ] to maximal values (Fig. 4) . The difference in NEM-S1-induced effects on k tr was observed only at intermediate levels of activation, where k tr was increased to values less than maximal with greater increases in k tr in cTnT trunc myocardium.
In vitro studies of thin filament proteins in the presence of TnT trunc suggest that Tm is held less tightly by Tn in its inhibitory position (3), thus reducing steric hindrance of myosin binding to actin. Results from the present study showing reduced cooperativity of activation and accelerated crossbridge kinetics during submaximal activation of TnT trunc myocardium support this view. Likewise, the greater activating effects of NEM-S1 on cross-bridge kinetics in TnT trunc myocardium can be explained in terms of increased likelihood of cross-bridge binding at low levels of activation.
Functional significance of cTnT trunc mutation. The primary function of the thin filament regulatory strand is to inhibit myosin binding in the absence of Ca 2ϩ and to relieve this inhibition in the presence of Ca 2ϩ . Several published reports show that incorporation of cTnT trunc into the thin filament impairs the ability of the regulatory strand to completely inhibit myosin cross-bridge cycling at very low Ca 2ϩ or in its absence (3, 14, 18) . Results from the present study support this view. Furthermore, incorporation of cTnT trunc into the thin filament appears to accelerate cross-bridge cycling at submaximal Ca 2ϩ both by increasing the responsiveness of thin filaments to the activating effects of Ca 2ϩ and strong-binding cross bridges and by increasing the rate of cross-bridge interaction with actin. Together, our results could account for deficits in global ventricular function, including incomplete diastolic relaxation, which leads to decreased ventricular filling and a lower ejection fraction due to impaired systolic function (19) .
